衰减型与经典型家族性腺瘤性息肉病的癌症风险:全国性队列与匹配非暴露个体比较
基于丹麦全国数据,将311例经典型家族性腺瘤性息肉病(CFAP)和134例衰减型(AFAP)患者与1600名匹配非暴露个体比较。CFAP和AFAP总体癌症风险均显著高于非暴露个体(HR分别为4.77和3.22),但CFAP与AFAP间无显著差异;CFAP死亡率显著升高(HR=2.96),AFAP死亡率无显著差异。
要点
- CFAP和AFAP总体癌症风险均显著高于非暴露个体,HR分别为4.77和3.22。
- CFAP与AFAP之间总体癌症风险无显著差异(HR=1.48,P=0.0646)。
- AFAP死亡率与非暴露个体无显著差异(HR=1.40,P=0.311),但AFAP癌症负担仍需持续监测。
核心结论
- 全国性数据显示AFAP与CFAP相比非暴露个体在特定癌症和死亡率上风险特征不同;AFAP的癌症负担需要对这些患者进行持续监测。
研究设计与样本
- 全国性队列研究,将丹麦所有已知FAP患者分类为CFAP或AFAP,并为每例患者匹配4名非暴露个体,分析总体及特定癌症风险和死亡率。
- 分析纳入311例CFAP患者、134例AFAP患者和1600名非暴露个体。
主要发现
- 总体癌症风险CFAP vs 非暴露个体HR=4.77(95%CI 3.61-6.32,P<0.001),AFAP vs 非暴露个体HR=3.22(95%CI 2.16-4.80,P<0.001)。
- CFAP vs AFAP总体癌症风险HR=1.48(95%CI 0.98-2.25,P=0.0646),无显著差异。
- 结肠癌风险CFAP vs 非暴露个体HR=2.16(95%CI 0.99-7.72,P=0.0522),AFAP vs 非暴露个体HR=2.72(95%CI 1.19-6.22,P=0.0177);CFAP vs AFAP HR=0.80(95%CI 0.32-2.00,P=0.6278)。
- 死亡率CFAP vs 非暴露个体HR=2.96(95%CI 2.04-4.28,P<0.001),AFAP vs 非暴露个体HR=1.40(95%CI 0.73-2.69,P=0.311)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Familial adenomatous polyposis (FAP) is caused by pathogenic variants in the APC gene. FAP is usually categorized according to phenotype: classical FAP (CFAP) and attenuated FAP (AFAP); the latter is considered to have a milder disease course. We aimed to assess the risk of overall and specific cancers in patients with CFAP and AFAP compared with matched, nonexposed individuals. METHODS: All known Danish patients with FAP were classified as either CFAP or AFAP and assigned 4 matched, nonexposed individuals. The risk of overall and specific cancers, and mortality were analyzed. RESULTS: The analysis included 311 patients with CFAP, 134 patients with AFAP, and 1,600 nonexposed individuals. The overall cancer risk was significantly higher for both patients with CFAP and AFAP than for nonexposed individuals, with hazard ratios (HRs) of 4.77 (95% confidence interval [CI], 3.61-6.32; P < 0.001) for CFAP and 3.22 (95% CI, 2.16-4.80; P < 0.001) for AFAP. No significant difference was observed when comparing CFAP and AFAP (HR = 1.48; 95% CI, 0.98-2.25; P = 0.0646). The HR of colonic cancer was 2.16 (95% CI, 0.99-7.72; P = 0.0522) and 2.72 (95% CI, 1.19-6.22; P = 0.0177 for CFAP and AFAP), respectively, compared with nonexposed and did not differ between patients with CFAP and AFAP (HR = 0.80; 95% CI, 0.32-2.00; P = 0.6278). Mortality was significantly higher in CFAP (HR = 2.96; 95% CI, 2.04-4.28; P < 0.001), but not in AFAP (HR = 1.40; 95% CI, 0.73-2.69; P = 0.311). DISCUSSION: Nationwide data reveal differing risk profiles for specific cancers and mortality in AFAP and CFAP compared with nonexposed individuals. The cancer burden of AFAP necessitates consistent monitoring of these patients.
引用
- Beck SH, Karstensen JG, Bülow S, et al. Cancer Risks in Attenuated and Classical Familial Adenomatous Polyposis: A Nationwide Cohort With Matched, Nonexposed Individuals. Am J Gastroenterol. 2024. PMID: 39471488. doi:10.14309/ajg.0000000000003167
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。